LSD1 inhibition ameliorates congenital dyserythropoietic anemia type II De-repressing SEC23A transcription via LSD1 inhibition or deletion of the SEC23A promoter sequence occupied by LSD1 compensates for SEC23B deficiency.

Epigentics Update - LSD1 inhibition ameliorates congenital dyserythropoietic anemia type II bit.ly/4srzOzk

Lei Yu and Rami Khoriaty @umich.edu in Sci Trans Med

#Epigenetics #LSD1 #HistoneDemethylation #Anemia #CDAII
---

Perfect for cancer, immunology, and aging research; epigenometech.com